Literature DB >> 14710357

Regulation of IGF-I receptor signaling in tumor cells.

R O'Connor1.   

Abstract

Signals from the IGF-IR and other members of the IR family contribute to the growth, survival, adhesion, and motility of tumor cells. These signals are initiated through recruitment of adapter proteins including the IRS family and Shc proteins, and are mediated through the PI3-kinase, mitogen activated protein (MAP) kinase and stress-activated protein kinase (SAPK) pathways. Regulation of signaling responses from the IGF-IR involves the actions of regulatory adapter proteins including RACK1 and Grb10 that recruit or sequester cytoplasmic proteins, and the actions of phosphatases including tyrosine PTP-1B, PTEN, and PP2A. This review focuses on the signaling pathways that are activated by the IGF-IR in tumor cells, the mechanisms of regulation of these pathways by adapter proteins and phosphatases, and how modulation of IGF-IR signaling could contribute to cancer progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710357     DOI: 10.1055/s-2004-814166

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  23 in total

Review 1.  mTOR signaling in cancer cell motility and tumor metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 2.  Role of mTOR signaling in tumor cell motility, invasion and metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2011-02       Impact factor: 3.272

3.  Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.

Authors:  Alexander Huether; Michael Hopfner; Andreas P Sutter; Viola Baradari; Detlef Schuppan; Hans Scherubl
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 4.  Metformin: a therapeutic opportunity in breast cancer.

Authors:  Ana M Gonzalez-Angulo; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

Review 5.  Insulin-like growth factor system and sporadic malignant melanoma.

Authors:  Ettore Capoluongo
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Exposure of decidualized HIESC to low oxygen tension and leucine deprivation results in increased IGFBP-1 phosphorylation and reduced IGF-I bioactivity.

Authors:  Majida Abu Shehab; Kyle Biggar; Sahil Sagar Singal; Karen Nygard; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2017-04-21       Impact factor: 4.102

7.  Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.

Authors:  Lei Liu; Long Chen; Yan Luo; Wenxing Chen; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Shile Huang
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

8.  ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.

Authors:  Craig I Campbell; James J Petrik; Roger A Moorehead
Journal:  Mol Cancer       Date:  2010-09-08       Impact factor: 27.401

9.  Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Authors:  Linda Yu; Katrin Saile; Carol D Swartz; Hong He; Xiaolin Zheng; Grace E Kissling; Xudong Di; Shantelle Lucas; Stanley J Robboy; Darlene Dixon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse.

Authors:  William R Swindell
Journal:  BMC Genomics       Date:  2009-12-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.